Regenxbio Inc (RGNX)

Cash & Equivalents

$36.49M

Quarterly · Period ending: · USD

RGNX logo

RGNX Cash & Equivalents

Latest reported$36.49M
RGNX Quarterly Cash & Equivalents (-$1.12M → $36.49M)
High-resolution chart · PNG

RGNX cash & equivalents history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regenxbio Inc Cash & Equivalents — Quarterly (USD)
Period endingCash & Equivalents (USD)
36,487,000
15,229,000
34,466,000
58,802,000
79,558,000
130,104,000
57,526,000
56,617,000
57,765,000
112,975,000
34,522,000
53,045,000
68,600,000
70,091,000
96,952,000
118,544,000
121,374,000
191,873,000
345,209,000
228,387,000
257,072,000
291,482,000
338,426,000
93,220,000
94,222,000
69,411,000
69,514,000
79,594,000
55,142,000
55,852,000
75,561,000
142,423,000
106,889,000
71,870,000
46,656,000
59,884,000
57,649,000
82,045,000
24,840,000
28,108,000
30,083,000
35,511,000
54,116,000
205,324,000
85,215,000
25,368,000
1,121,000
-1,119,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.